EUVIMEDEUVIMED entdecken
Crossref

Cannabidiol Anticonvulsant Effects Against Lithium-Pilocarpine-Induced Status Epilepticus in Male Rats Are Mediated by Neuroinflammation Modulation and Cannabinoids 1 (CB1), But Not CB2 and GABA A Receptors

Mahla Masoumi, Mohammad Amin Manavi, Razieh Mohammad Jafari, Alireza Mirzaei, Keshvad Hedayatyanfard, Mohammad Taghi Beigmohammadi, Ahmad Reza Dehpour iD

Cannabis & Cannabinoid Research · 2024

DOI: 10.1089/can.2023.0067 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cannabis & Cannabinoid Research, 2024. Verfasst von Mahla Masoumi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Pilocarpine, Status Epilepticus, Anticonvulsants, Cannabidiol. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 94 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Status epilepticus (SE) is a series of seizures that can lead to serious neurological damages. Cannabidiol (CBD) is extracted from the cannabis plant, which has been approved as an antiseizure medication. This study aimed to determine the efficacy of various doses of CBD on lithium-pilocarpine-induced SE in rats and possible involvement of multiple pharmacological pathways. We hypothesized that cannabinoid receptors type 1 (CB1) and CB2, as well as GABA A receptors, might have important roles in the anticonvulsant effects of CBD against SE by its anti-inflammatory effects.

Methods

SE was induced by intraperitoneal (i.p.) injection of lithium (127 mg/kg, i.p.) and pilocarpine (60 mg/kg, i.p., 20 h after lithium). Forty-two male rats were divided into seven groups (including control and sham groups), and the treated groups received different doses of CBD (1, 3, 5, 10, and 25 mg/kg, i.p.). SE score was recorded over the next 2 h following pilocarpine injection. Then, we measured the levels of pro-inflammatory cytokines, including interleukin (IL)-lβ and tumor necrosis factor (TNF)-α, using ELISA kits. Also we analyzed the expression of CB1, CB2, and GABA A receptors using the Western blot technique.

Results

CBD at 5 mg/kg significantly reduced Racine's scale and duration of seizures, and increased the onset time of seizure. Moreover, CBD 5 mg/kg caused significant reductions in the elevated levels of IL-lβ and TNF-α, as well as a significant increase in the decreased level of CB1 receptor expression compared to the control group. In other word, CBD reverted the effects of SE in terms of neuroinflammation and CB1 receptor. Based on the obtained results, CBD was not able to restore the declined levels of CB2 or GABA A receptors.

Conclusion

Our study found anticonvulsant effects of CBD on the SE rat model induced by lithium-pilocarpine with probable involvement of CB1 receptors and anti-inflammatory effects by reducing IL-1β and TNF-α markers independent of CB2 and GABA A receptors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PilocarpineStatus EpilepticusAnticonvulsantsCannabidiolReceptor, Cannabinoid, CB2Receptors, GABA-AReceptor, Cannabinoid, CB1AnimalsMaleRatsNeuroinflammatory DiseasesLithiumRats, Sprague-Dawley

Stichwörter der Autor:innen

GABAcannabidiolcannabinoid receptors (CB)inflammationlithium-pilocarpinestatus epilepticus seizure

Substanzen

PilocarpineAnticonvulsantsCannabidiolReceptor, Cannabinoid, CB2Receptors, GABA-AReceptor, Cannabinoid, CB1LithiumCnr2 protein, rat

Autor:innen und Institutionen

  • Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Intensive Care, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Ahmad Reza Dehpour

Zitieren

APA

Masoumi, M., Manavi, M. A., Mohammad Jafari, R., Mirzaei, A., Hedayatyanfard, K., Beigmohammadi, M. T., & Dehpour, A. R. (2024). Cannabidiol Anticonvulsant Effects Against Lithium-Pilocarpine-Induced Status Epilepticus in Male Rats Are Mediated by Neuroinflammation Modulation and Cannabinoids 1 (CB1), But Not CB2 and GABA A Receptors. Cannabis & Cannabinoid Research. https://doi.org/10.1089/can.2023.0067

Vancouver

Masoumi M, Manavi MA, Mohammad Jafari R, Mirzaei A, Hedayatyanfard K, Beigmohammadi MT, et al. Cannabidiol Anticonvulsant Effects Against Lithium-Pilocarpine-Induced Status Epilepticus in Male Rats Are Mediated by Neuroinflammation Modulation and Cannabinoids 1 (CB1), But Not CB2 and GABA A Receptors. Cannabis & Cannabinoid Research. 2024. doi:10.1089/can.2023.0067

BibTeX
@article{Masoumi2024,
  author = {Masoumi, Mahla and Manavi, Mohammad Amin and Mohammad Jafari, Razieh and Mirzaei, Alireza and Hedayatyanfard, Keshvad and Beigmohammadi, Mohammad Taghi and Dehpour, Ahmad Reza},
  title = {Cannabidiol Anticonvulsant Effects Against Lithium-Pilocarpine-Induced Status Epilepticus in Male Rats Are Mediated by Neuroinflammation Modulation and Cannabinoids 1 (CB1), But Not CB2 and GABA A Receptors},
  journal = {Cannabis & Cannabinoid Research},
  year = {2024},
  doi = {10.1089/can.2023.0067}
}
Kostenlos starten →